An exploratory analysis on gene-environment interactions for Parkinson disease

Neurobiology of Aging

Volumn 33, Issue 10, 2012, Pages 2528.e1-2528.e6

  Gao, Jianjun ^a   Nalls, Michael A ^b   Shi, Min ^a   Joubert, Bonnie R ^a   Hernandez, Dena G ^b   Huang, Xuemei ^c   Hollenbeck, Albert ^d   Singleton, Andrew B ^b   Chen, Honglei ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d AARP   (United States)

Author keywords

Gene environment interactions; Genome wide association study; Parkinson disease (PD)

Indexed keywords

ALPHA SYNUCLEIN; CAFFEINE; HLA ANTIGEN; LEUCINE RICH REPEAT KINASE 2; TAU PROTEIN; GLUCOSE TRANSPORTER; LRRK2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SLC2A13 PROTEIN, HUMAN;

AGED; ALLELE; ALPHA SYNUCLEIN GENE; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; EXPLORATORY RESEARCH; FAMILY HISTORY; FEEDING BEHAVIOR; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HUMAN LEUKOCYTE ANTIGEN GENE; LEUCINE RICH REPEAT KINASE 2 GENE; MAJOR CLINICAL STUDY; MALE; MICROTUBULE ASSOCIATED PROTEIN TAU GENE; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SLC2A13 GENE; SMOKING HABIT; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; MIDDLE AGED; ONSET AGE; RISK; SMOKING; STATISTICS;

AGE OF ONSET; AGED; CAFFEINE; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RISK; SMOKING;

EID: 84864386591     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.06.007     Document Type: Article

References (19)

1. Ascherio A., Zhang S.M., Hernán M.A., Kawachi I., Colditz G.A., Speizer F.E., Willett W.C. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann. Neurol 2001, 50:56-63.
2. Chen H., Huang X., Guo X., Mailman R.B., Park Y., Kamel F., Umbach D.M., Xu Q., Hollenbeck A., Schatzkin A., Blair A. Smoking duration, intensity, and risk of Parkinson disease. Neurology 2010, 74:878-884.
3. Do C.B., Tung J.Y., Dorfman E., Kiefer A.K., Drabant E.M., Francke U., Mountain J.L., Goldman S.M., Tanner C.M., Langston J.W., Wojcicki A., Eriksson N. Web-based genome-wide association study identifies two novel Loci and a substantial genetic component for Parkinson's disease. PLoS Genet 2011, 7:e1002141.
4. Gao J., Xu H., Weinberg C., Huang X., Park Y., Hollenbeck A., Blair A., Schatzkin A., Burch L., Chen H. An exploratory study on the CHRNA3-CHRNA5-CHRNB4 cluster, smoking, and Parkinson's disease. Neurodegener. Dis 2011, 8:296-299.
5. Gatto N.M., Rhodes S.L., Manthripragada A.D., Bronstein J., Cockburn M., Farrer M., Ritz B. α-Synuclein gene may interact with environmental factors in increasing risk of Parkinson's disease. Neuroepidemiology 2010, 35:191-195.
6. Hamza T.H., Zabetian C.P., Tenesa A., Laederach A., Montimurro J., Yearout D., Kay D.M., Doheny K.F., Paschall J., Pugh E., Kusel V.I., Collura R., Roberts J., Griffith A., Samii A., Scott W.K., Nutt J., Factor S.A., Payami H. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat. Genet 2010, 42:781-785.
7. Hong D.P., Fink A.L., Uversky V.N. Smoking and Parkinson's disease: does nicotine affect alpha-synuclein fibrillation?. Biochim. Biophys. Acta 2009, 1794:282-290.
8. A two-stage meta-analysis identifies several new Loci for Parkinson's disease. PLoS Genet 2011, 7:e1002142. International Parkinson's Disease Genomics Consortium (IPDGC), Wellcome Trust Case Control Consortium 2 (WTCCC2).
9. Nalls M.A., Plagnol V., Hernandez D.G., Sharma M., Sheerin U.M., Saad M., Simon-Sanchez J., Schulte C., Lesage S., Sveinbjornsdottir S., Stefansson K., Martinez M., Hardy J., Heutink P., Brice A., Gasser T., Singleton A.B., Wood N.W. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011, 377:641-649. International Parkinson Disease Genomics Consortium.
10. McCulloch C.C., Kay D.M., Factor S.A., Samii A., Nutt J.G., Higgins D.S., Griffith A., Roberts J.W., Leis B.C., Montimurro J.S., Zabetian C.P., Payami H. Exploring gene-environment interactions in Parkinson's disease. Hum. Genet 2008, 123:257-265.
11. Miyake Y., Tsuboi Y., Koyanagi M., Fujimoto T., Shirasawa S., Kiyohara C., Tanaka K., Fukushima W., Sasaki S., Yamada T., Oeda T., Miki T., Kawamura N., Sakae N., Fukuyama H., Hirota Y., Nagai M. LRRK2 Gly2385Arg polymorphism, cigarette smoking, and risk of sporadic Parkinson's disease: a case-control study in Japan. J. Neurol. Sci 2010, 297:15-18. Fukuoka Kinki Parkinson's Disease Study Group.
12. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet 2007, 81:559-575.
13. Ritz B., Ascherio A., Checkoway H., Marder K.S., Nelson L.M., Rocca W.A., Ross G.W., Strickland D., Van Den Eeden S.K., Gorell J. Pooled analysis of tobacco use and risk of Parkinson disease. Arch. Neurol 2007, 64:990-997.
14. Ross G.W., Abbott R.D., Petrovitch H., Morens D.M., Grandinetti A., Tung K.H., Tanner C.M., Masaki K.H., Blanchette P.L., Curb J.D., Popper J.S., White L.R. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 2000, 283:2674-2679.
15. Ross O.A., Soto-Ortolaza A.I., Heckman M.G., Aasly J.O., Abahuni N., Annesi G., Bacon J.A., Bardien S., Bozi M., Brice A., Brighina L., Van Broeckhoven C., Carr J., Chartier-Harlin M.C., Dardiotis E., Dickson D.W., Diehl N.N., Elbaz A., Ferrarese C., Ferraris A., Fiske B., Gibson J.M., Gibson R., Hadjigeorgiou G.M., Hattori N., Ioannidis J.P., Jasinska-Myga B., Jeon B.S., Kim Y.J., Klein C., Kruger R., Kyratzi E., Lesage S., Lin C.H., Lynch T., Maraganore D.M., Mellick G.D., Mutez E., Nilsson C., Opala G., Park S.S., Puschmann A., Quattrone A., Sharma M., Silburn P.A., Sohn Y.H., Stefanis L., Tadic V., Theuns J., Tomiyama H., Uitti R.J., Valente E.M., van de Loo S., Vassilatis D.K., Vilarino-Guell C., White L.R., Wirdefeldt K., Wszolek Z.K., Wu R.M., Farrer M.J. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Lancet Neurol 2011, 10:898-908. Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium.
16. Satake W., Nakabayashi Y., Mizuta I., Hirota Y., Ito C., Kubo M., Kawaguchi T., Tsunoda T., Watanabe M., Takeda A., Tomiyama H., Nakashima K., Hasegawa K., Obata F., Yoshikawa T., Kawakami H., Sakoda S., Yamamoto M., Hattori N., Murata M., Nakamura Y., Toda T. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat. Genet 2009, 41:1303-1307.
17. Schatzkin A., Subar A.F., Thompson F.E., Harlan L.C., Tangrea J., Hollenbeck A.R., Hurwitz P.E., Coyle L., Schussler N., Michaud D.S., Freedman L.S., Brown C.C., Midthune D., Kipnis V. Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am. J. Epidemiol 2001, 154:1119-1125.
18. Scholz S.W., Houlden H., Schulte C., Sharma M., Li A., Berg D., Melchers A., Paudel R., Gibbs J.R., Simon-Sanchez J., Paisan-Ruiz C., Bras J., Ding J., Chen H., Traynor B.J., Arepalli S., Zonozi R.R., Revesz T., Holton J., Wood N., Lees A., Oertel W., Wüllner U., Goldwurm S., Pellecchia M.T., Illig T., Riess O., Fernandez H.H., Rodriguez R.L., Okun M.S., Poewe W., Wenning G.K., Hardy J.A., Singleton A.B., Del Sorbo F., Schneider S., Bhatia K.P., Gasser T. SNCA variants are associated with increased risk for multiple system atrophy. Ann. Neurol 2009, 65:610-614.
19. Simón-Sánchez J., Schulte C., Bras J.M., Sharma M., Gibbs J.R., Berg D., Paisan-Ruiz C., Lichtner P., Scholz S.W., Hernandez D.G., Krüger R., Federoff M., Klein C., Goate A., Perlmutter J., Bonin M., Nalls M.A., Illig T., Gieger C., Houlden H., Steffens M., Okun M.S., Racette B.A., Cookson M.R., Foote K.D., Fernandez H.H., Traynor B.J., Schreiber S., Arepalli S., Zonozi R., Gwinn K., van der Brug M., Lopez G., Chanock S.J., Schatzkin A., Park Y., Hollenbeck A., Gao J., Huang X., Wood N.W., Lorenz D., Deuschl G., Chen H., Riess O., Hardy J.A., Singleton A.B., Gasser T. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet 2009, 41:1308-1312.